Leucemia mieloide cronica - Alzheimer

from Salute e Società · host Marco Caracciolo

1. Una nuova speranza per chi convive con la leucemia mieloide cronica. Asciminib, farmaco innovativo della nuova generazione degli STAMP inibitori, è ora rimborsato dal Servizio Sanitario Nazionale.2. Alzheimer, presentate le nuove linee guida multidisciplinari che definiscono criteri, percorsi e strumenti per l’introduzione in terapia dei farmaci di nuova generazione.

Episode metadata supplied by the publisher feed · Published Oct 28, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Leucemia mieloide cronica - Alzheimer

0:00 6:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

DECODIFICAMOS EL MENSAJE DE AVI LOEB. ¿PODRÍA SER UNA NAVE ALIENÍGENA? CON BARTHÉLEMY D'ANS

Nov 2, 2025 ·183m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Salute e Società?

This episode is 6 minutes long.

When was this Salute e Società episode published?

This episode was published on October 28, 2025.

Can I download this Salute e Società episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!